Literature DB >> 28653210

Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.

N Joshi1, T M Rolheiser2, J D Fisk3, J R McKelvey4, K Schoffer4, G Phillips5, M Armstrong6, M N Khan7, R A Leslie8, B Rusak2,9, H A Robertson2,4,10, K P Good11,12.   

Abstract

Parkinson's disease (PD) is a progressive neurological disorder characterized by motor symptoms as well as severe deficits in olfactory function and microstructural changes in olfactory brain regions. Because of the evidence of asymmetric neuropathological features in early-stage PD, we examined whether lateralized microstructural changes occur in olfactory brain regions and the substantia nigra in a group of early-stage PD patients. Using diffusion tensor imaging (DTI) and the University of Pennsylvania Smell Identification Test (UPSIT), we assessed 24 early-stage PD patients (Hoehn and Yahr stage 1 or 2) and 26 healthy controls (HC). We used DTI and a region of interest (ROI) approach to study the microstructure of the left and right anterior olfactory structures (AOS; comprising the olfactory bulbs and anterior end of the olfactory tracts) and the substantia nigra (SN). PD patients had reduced UPSIT scores relative to HC and showed increased mean diffusivity (MD) in the SN, with no lateralized differences. Significant group differences in fractional anisotropy (FA) and MD were seen in the AOS, but these differences were restricted to the right side and were not associated with the primary side of motor symptoms amongst PD patients. No associations were observed between lateralized motor impairment and lateralized microstructural changes in AOS. Impaired olfaction and microstructural changes in AOS are useful for early identification of PD but asymmetries in AOS microstructure seem unrelated to the laterality of PD motor symptoms.

Entities:  

Keywords:  Anterior olfactory structures; Diffusion tensor imaging; Olfaction; Parkinson’s; Substantia nigra

Mesh:

Year:  2017        PMID: 28653210     DOI: 10.1007/s00415-017-8555-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  56 in total

Review 1.  MDS research criteria for prodromal Parkinson's disease.

Authors:  Daniela Berg; Ronald B Postuma; Charles H Adler; Bastiaan R Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda Halliday; Lawrence Joseph; Anthony E Lang; Inga Liepelt-Scarfone; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

2.  Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot study.

Authors:  A Mueller; N D Abolmaali; A R Hakimi; T Gloeckler; B Herting; H Reichmann; T Hummel
Journal:  J Neural Transm (Vienna)       Date:  2005-02-15       Impact factor: 3.575

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

4.  Olfactory loss may be a first sign of idiopathic Parkinson's disease.

Authors:  Antje Haehner; Thomas Hummel; Cornelia Hummel; Ulrike Sommer; Susann Junghanns; Heinz Reichmann
Journal:  Mov Disord       Date:  2007-04-30       Impact factor: 10.338

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 6.  Olfaction and Parkinson's syndromes: its role in differential diagnosis.

Authors:  Regina Katzenschlager; Andrew J Lees
Journal:  Curr Opin Neurol       Date:  2004-08       Impact factor: 5.710

Review 7.  Alpha-Synuclein as a Biomarker for Parkinson's Disease.

Authors:  Anzari Atik; Tessandra Stewart; Jing Zhang
Journal:  Brain Pathol       Date:  2016-05       Impact factor: 6.508

8.  Case control study of diffusion tensor imaging in Parkinson's disease.

Authors:  L-L Chan; H Rumpel; K Yap; E Lee; H-V Loo; G-L Ho; S Fook-Chong; Y Yuen; E-K Tan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-05       Impact factor: 10.154

9.  Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Authors:  R L Doty; D A Deems; S Stellar
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

10.  Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.

Authors:  Stefan T Schwarz; Maryam Abaei; Vamsi Gontu; Paul S Morgan; Nin Bajaj; Dorothee P Auer
Journal:  Neuroimage Clin       Date:  2013-10-14       Impact factor: 4.881

View more
  6 in total

1.  Specific intranasal and central trigeminal electrophysiological responses in Parkinson's disease.

Authors:  Cécilia Tremblay; Rosa Emrich; Annachiara Cavazzana; Lisa Klingelhoefer; Moritz D Brandt; Thomas Hummel; Antje Haehner; Johannes Frasnelli
Journal:  J Neurol       Date:  2019-08-26       Impact factor: 4.849

2.  Alteration of Diffusion-Tensor Magnetic Resonance Imaging Measures in Brain Regions Involved in Early Stages of Parkinson's Disease.

Authors:  Nan-Kuei Chen; Ying-Hui Chou; Mark Sundman; Patrick Hickey; Willard S Kasoff; Adam Bernstein; Theodore P Trouard; Tanya Lin; Steven Z Rapcsak; Scott J Sherman; Carol P Weingarten
Journal:  Brain Connect       Date:  2018-08

3.  Assessing White Matter Pathology in Early-Stage Parkinson Disease Using Diffusion MRI: A Systematic Review.

Authors:  Maurizio Bergamino; Elizabeth G Keeling; Virendra R Mishra; Ashley M Stokes; Ryan R Walsh
Journal:  Front Neurol       Date:  2020-05-14       Impact factor: 4.003

4.  White Matter Microstructural Alterations in Newly Diagnosed Parkinson's Disease: A Whole-Brain Analysis Using dMRI.

Authors:  Jun-Yeop Kim; Jae-Hyuk Shim; Hyeon-Man Baek
Journal:  Brain Sci       Date:  2022-02-07

5.  A diffusion-matched principal component analysis (DM-PCA) based two-channel denoising procedure for high-resolution diffusion-weighted MRI.

Authors:  Nan-Kuei Chen; Hing-Chiu Chang; Ali Bilgin; Adam Bernstein; Theodore P Trouard
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.752

6.  Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson's disease.

Authors:  Ming-Ching Wen; Zheyu Xu; Zhonghao Lu; Ling Ling Chan; Eng King Tan; Louis C S Tan
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.